Open Access
Metastatic Renal Cancer: What Role for Everolimus?
Clinical Medicine Reviews in Oncology · 2010
DOI: 10.4137/cmro.s1551 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Medicine Reviews in Oncology, 2010. Verfasst von Franck A Belibi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Renal Diseases and Hypertension, University of Colorado Denver, Aurora, CO, USA. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
everolimusmTORrenal cell cancer
Autor:innen und Institutionen
- Division of Renal Diseases and Hypertension, University of Colorado Denver, Aurora, CO, USA.
Förderung
- NIDDK NIH HHS
Zitieren
APA
Belibi, F. A., & Edelstein, C. L. (2010). Metastatic Renal Cancer: What Role for Everolimus?. Clinical Medicine Reviews in Oncology. https://doi.org/10.4137/cmro.s1551
Vancouver
Belibi FA, Edelstein CL. Metastatic Renal Cancer: What Role for Everolimus?. Clinical Medicine Reviews in Oncology. 2010. doi:10.4137/cmro.s1551
BibTeX
@article{Belibi2010,
author = {Belibi, Franck A and Edelstein, Charles L},
title = {Metastatic Renal Cancer: What Role for Everolimus?},
journal = {Clinical Medicine Reviews in Oncology},
year = {2010},
doi = {10.4137/cmro.s1551}
}
EUVIMED